Giorgio Ottaviani
InvestorOperating Partner at Versant Ventures
Find your path to Giorgio
Sign up to see every warm intro you have to Giorgio
- Paths you didn't know you had: your email and LinkedIn already hold routes to Giorgio. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Operating Partner at Versant and SVP of Preclinical Development at the firm's Ridgeline Discovery Engine, with drug development expertise. He joined Ridgeline in 2018 from Roche, where he led DMPK-PD project leaders and headed non-clinical safety in Shanghai, and previously worked at Novartis and Merck-Serono. He holds a Ph.D. in Pharmaceutical Chemistry from the University of Geneva and is a certified toxicologist (DABT).
Colleagues at Versant Ventures
Frequently asked questions
- Who is Giorgio Ottaviani?
- Operating Partner at Versant and SVP of Preclinical Development at the firm's Ridgeline Discovery Engine, with drug development expertise. He joined Ridgeline in 2018 from Roche, where he led DMPK-PD project leaders and headed non-clinical safety in Shanghai, and previously worked at Novartis and Merck-Serono. He holds a Ph.D. in Pharmaceutical Chemistry from the University of Geneva and is a certified toxicologist (DABT).
- Where does Giorgio Ottaviani work?
- Giorgio Ottaviani is Operating Partner at Versant Ventures.
About this profile. Compiled from public sources — Versant Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







